All In MedTech

Device Trial Radar · NCT07089615

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Prospective, Open Label, Pivotal Study of the Accuracy of the CapsoCam® Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference

Last checked: Nov 19, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

330

Planned (sponsor's estimate)

Start

Jun 26, 2025

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Capso Vision, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 28, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Note: This is the same study protocol as NCT04607746 with slight changes to how the videos will be read and a 2nd generation capsule is being studied. The purpose of this study is to evaluate the safety and effectiveness of CapsoCam® Colon (CV-3) endoscope system for the detection of colonic polyps and to show that AI-based CADe improves the polyp-detection accuracy and efficiency of capsule video readers. It will use colonoscopy results as a reference. The participant will: 1. prep for and swallow a study capsule and then 2. prep for and undergo a colonoscopy either the following day or 3-6 weeks later

Conditions

  • Colonic Polyps

Interventions

  • Capsule swallowDevice

    Participant will swallow the investigational device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Positive Percentage AgreementTime frame: From capsule swallow to Colonoscopy - up to 6 weeks
  2. Negative Percentage AgreementTime frame: From Capsule swallow to colonoscopy - Up to 6 weeks

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • SB Gastro Clinical Research

    Chula Vista, California · Recruiting

  • Gastro Care Institute

    Lancaster, California · Recruiting

  • Knowledge Research Center

    Orange, California · Recruiting

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.